Sign In
Buy NNVC
$1.31
-0.0100 (-0.758%)
At Close: Jun 23, 2026
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
12:00am, Thursday, 09'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 8)
Akero Therapeutics Inc (...
Nanoviricides Commences Underwritten Public Offering of Common Stock
09:55pm, Wednesday, 08'th Jul 2020
SHELTON, CT / ACCESSWIRE / July 8, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines pl
Covid-19 Research Update: The Stars and the Question Marks
09:50pm, Wednesday, 08'th Jul 2020
While giants like Gilead Sciences and Pfizer are progressing well, many small players have witnessed setbacks in their Covid-19 research Continue reading...
SHELTON, CT / ACCESSWIRE / July 8, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines pl
NanoViricides Announces Addition to Russell Microcap(R) Index
10:15am, Tuesday, 30'th Jun 2020
SHELTON, CT / ACCESSWIRE / June 30, 2020 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines
Covid-Linked Stocks Rally on Trump’s ‘Surprise’ Hint, Day Trades - BNN Bloomberg
05:14pm, Thursday, 25'th Jun 2020
Drug and vaccine makers working on Covid-19 medicines rallied after President Donald Trump hinted at a “big surprise” coming soon, while day traders continued to favor a handful of smaller develop
NanoViricides: Sufficient Funding for Covid-19 Research
03:05pm, Thursday, 25'th Jun 2020
After two successful rounds of fundraising in 2020, the company has adequate cash to move forward Continue reading...
Insights into the Global Coronavirus Vaccine Market to 2027 - Drivers, Restraints, Opportunities and Threats - ResearchAndMarkets.com
12:00am, Thursday, 25'th Jun 2020
The
SHELTON, CT / ACCESSWIRE / June 23, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedi
Short Interest in NanoViricides Inc (NYSEAMERICAN:NNVC) Decreases By 30.8%
02:02am, Friday, 19'th Jun 2020
NanoViricides Inc (NYSEAMERICAN:NNVC) was the recipient of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totalling 303,800 shares, a decr
NanoViricides (NYSEAMERICAN:NNVC) Trading Up 0.7%
07:02am, Wednesday, 17'th Jun 2020
NanoViricides Inc (NYSEAMERICAN:NNVC)’s share price was up 0.7% during mid-day trading on Monday . The company traded as high as $6.94 and last traded at $6.94, approximately 4,417 shares were trade
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 8) * Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN)
